Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

LH

Labcorp (LH)

Labcorp Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:LH
일자시간출처헤드라인심볼기업
2024/05/1805:57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:LHLabcorp Holdings Inc
2024/05/1805:45Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:LHLabcorp Holdings Inc
2024/05/1805:41Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNYSE:LHLabcorp Holdings Inc
2024/05/1805:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:31Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:23Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:23Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
2024/05/1805:10Edgar (US Regulatory)Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b)NYSE:LHLabcorp Holdings Inc
2024/05/1705:19Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
2024/05/1621:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
2024/05/1521:00PR Newswire (US)Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during PregnancyNYSE:LHLabcorp Holdings Inc
2024/05/1501:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLabcorp Holdings Inc
2024/05/0821:08Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
2024/05/0819:59PR Newswire (US)Labcorp to Webcast Its Annual Meeting of ShareholdersNYSE:LHLabcorp Holdings Inc
2024/05/0805:05PR Newswire (US)Invitae Receives Court Approval for Sale to LabcorpNYSE:LHLabcorp Holdings Inc
2024/05/0705:40Edgar (US Regulatory)Form PX14A6G - Notice of exempt solicitation submitted by non-managementNYSE:LHLabcorp Holdings Inc
2024/04/2920:00PR Newswire (US)Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BNYSE:LHLabcorp Holdings Inc
 검색 관련기사 보기:NYSE:LH